Dihexa (Capsules)

Research Applications

• Neuroscience: Dihexa is studied as a potent HGF receptor system agonist with approximately ten million times greater activity than BDNF in promoting synaptic connectivity. Research examines its mechanism of hepatocyte growth factor (HGF)/c-Met receptor activation, the resulting enhancement of dendritic spine formation, synaptogenesis, and long-term potentiation. These effects position it as one of the most powerful nootropic compounds identified to date.
• Alzheimer's Disease: Dihexa is studied in Alzheimer's disease models for its ability to rescue cognitive deficits and restore memory function. Research demonstrates improvement in spatial memory, novel object recognition, and associative learning in transgenic AD mice. Studies examine whether HGF pathway activation can counteract synaptic loss, amyloid toxicity, and the cognitive decline characteristic of neurodegenerative disease progression.
• Nootropic Science: Dihexa is studied as a benchmark compound in nootropic research due to its unprecedented potency in promoting neural connectivity. Research profiles its cognitive enhancement effects across multiple domains including memory consolidation, learning rate, and cognitive flexibility. Studies compare its efficacy, duration of action, and mechanism against established nootropics including racetams, peptide nootropics, and neurotrophic factors.
• Blood-Brain Barrier: Dihexa is notable for oral bioavailability and CNS activity despite being a hexapeptide. Research examines the structural features enabling blood-brain barrier penetration, the pharmacokinetics of oral versus parenteral administration, and the brain tissue distribution following systemic absorption. These studies inform peptide drug design for CNS-active therapeutics where oral delivery is preferred.